JP2021532158A5 - - Google Patents

Info

Publication number
JP2021532158A5
JP2021532158A5 JP2021505202A JP2021505202A JP2021532158A5 JP 2021532158 A5 JP2021532158 A5 JP 2021532158A5 JP 2021505202 A JP2021505202 A JP 2021505202A JP 2021505202 A JP2021505202 A JP 2021505202A JP 2021532158 A5 JP2021532158 A5 JP 2021532158A5
Authority
JP
Japan
Prior art keywords
halo
alkoxy
alkyl
thioalkoxy
sulfhydryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021505202A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021532158A (ja
JP7613743B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/044278 external-priority patent/WO2020028461A1/en
Publication of JP2021532158A publication Critical patent/JP2021532158A/ja
Publication of JP2021532158A5 publication Critical patent/JP2021532158A5/ja
Application granted granted Critical
Publication of JP7613743B2 publication Critical patent/JP7613743B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021505202A 2018-07-31 2019-07-31 転移性癌および化学療法抵抗性癌の治療のためのテトラヒドロキノリノ誘導体 Active JP7613743B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862712434P 2018-07-31 2018-07-31
US62/712,434 2018-07-31
PCT/US2019/044278 WO2020028461A1 (en) 2018-07-31 2019-07-31 Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers

Publications (3)

Publication Number Publication Date
JP2021532158A JP2021532158A (ja) 2021-11-25
JP2021532158A5 true JP2021532158A5 (cg-RX-API-DMAC10.html) 2022-08-04
JP7613743B2 JP7613743B2 (ja) 2025-01-15

Family

ID=67734803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021505202A Active JP7613743B2 (ja) 2018-07-31 2019-07-31 転移性癌および化学療法抵抗性癌の治療のためのテトラヒドロキノリノ誘導体

Country Status (8)

Country Link
US (2) US12162855B2 (cg-RX-API-DMAC10.html)
EP (1) EP3830079A1 (cg-RX-API-DMAC10.html)
JP (1) JP7613743B2 (cg-RX-API-DMAC10.html)
CN (1) CN112638881B (cg-RX-API-DMAC10.html)
AU (1) AU2019315444B2 (cg-RX-API-DMAC10.html)
CA (1) CA3107120A1 (cg-RX-API-DMAC10.html)
IL (1) IL280395B2 (cg-RX-API-DMAC10.html)
WO (1) WO2020028461A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL280395B2 (en) 2018-07-31 2025-04-01 Univ Princeton History of tetrahydroquinolino for the treatment of metastatic and chemotherapy-resistant cancer
CA3168533A1 (en) * 2020-01-24 2021-07-29 The Trustees Of Princeton University Heterocyclic compounds and uses thereof
GB202019475D0 (en) * 2020-12-10 2021-01-27 Cancer Research Tech Ltd Therapeutic compounds and their use
JP7781391B2 (ja) * 2021-04-22 2025-12-08 カヨセラ インコーポレイテッド 複素環式化合物及びその使用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126270A (ja) * 1983-12-14 1985-07-05 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPS61145162A (ja) * 1984-12-19 1986-07-02 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
DE3701277A1 (de) 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
JPH01319453A (ja) * 1988-06-22 1989-12-25 Wakamoto Pharmaceut Co Ltd 新規ベンゾキノン誘導体
EP1626962B1 (en) 2003-05-12 2007-02-28 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
JP4823914B2 (ja) * 2003-11-07 2011-11-24 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド Fgfr3の阻害および多発性骨髄腫の治療
EP1718306A2 (en) * 2004-02-20 2006-11-08 Chiron Corporation Modulation of inflammatory and metastatic processes
JP2006349902A (ja) * 2005-06-15 2006-12-28 Fujifilm Holdings Corp 黒白熱現像感光材料
WO2007128884A1 (en) * 2006-05-09 2007-11-15 Oy Jurilab Ltd Novel genes and markers in type 2 diabetes and obesity
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
WO2013027168A1 (en) 2011-08-22 2013-02-28 Pfizer Inc. Novel heterocyclic compounds as bromodomain inhibitors
DK3107899T3 (da) * 2014-02-19 2020-11-16 Aviv Therapeutics Inc Mitokondriel aldehyddehydrogenase 2 (aldh2)-bindende polycykliske amider og anvendelse deraf til cancerbehandling
WO2015173169A1 (en) 2014-05-12 2015-11-19 Fondazione Istituto Italiano Di Tecnologia Substituted benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments
SG10201900631TA (en) 2014-08-01 2019-02-27 Nuevolution As Compounds active towards bromodomains
IL280395B2 (en) 2018-07-31 2025-04-01 Univ Princeton History of tetrahydroquinolino for the treatment of metastatic and chemotherapy-resistant cancer
CA3168533A1 (en) 2020-01-24 2021-07-29 The Trustees Of Princeton University Heterocyclic compounds and uses thereof
GB202019475D0 (en) 2020-12-10 2021-01-27 Cancer Research Tech Ltd Therapeutic compounds and their use
JP7781391B2 (ja) 2021-04-22 2025-12-08 カヨセラ インコーポレイテッド 複素環式化合物及びその使用

Similar Documents

Publication Publication Date Title
JP2007511504A5 (cg-RX-API-DMAC10.html)
JP2013503139A5 (cg-RX-API-DMAC10.html)
RU2003130268A (ru) Производные 4,5-дигидро-1h-пиразола, обладающие сильной cb1-антагонистической активностью
SK50793A3 (en) Method for preparing taxane derivatives, novel derivatives thereby obtained and pharmaceutical compositions containing same
JP2006507313A5 (cg-RX-API-DMAC10.html)
ES2377465T3 (es) Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios
US20110160228A1 (en) Dihydro-iso-ca-4 and analogues: potent cytotoxics, inhibitors of tubulin polymerization
CA2963390C (en) Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
CN103664689A (zh) 对癌细胞微管蛋白聚合有抑制作用的一类查尔酮肟衍生物及其制备方法
US20100298402A1 (en) Stilbene derivatives as pstat3/il-6 inhibitors
JP2017503753A5 (cg-RX-API-DMAC10.html)
RU2007121697A (ru) Гидроксибензоатные соли метаникотиновых соединений
IL321128A (en) Thiadiazolyl derivatives as dna polymerase theta inhibitors and uses thereof
JP2009527479A5 (cg-RX-API-DMAC10.html)
KR102304622B1 (ko) 신규한 구조를 갖는 화합물, 이를 포함하는 착물, 항암용 약학 조성물 및 항암제
JP2015504917A (ja) Mogat−2阻害剤として有用な新規モルホリニル誘導体
CA2423220A1 (en) Modified prodrug forms of ap/amp
US8273768B2 (en) Iso CA-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization
CN112175014B (zh) 一种一氧化氮供体型四价铂衍生物、制备方法及其医药用途
CA2511242A1 (en) Inhibitors of human tumor-expressed ccxckr2
JP2005501121A5 (cg-RX-API-DMAC10.html)
WO2010109008A1 (en) Prodrugs of substituted 3-(4-hydroxyphenyl)-indolin-2-ones
CN101671301A (zh) 杂环取代的二苯脲类衍生物及其用途
CN103183627B (zh) 1,2-二芳基-5-取代-1h-吡咯类化合物及其制备方法与应用
WO2024063095A1 (ja) 放射標識されたチロシン誘導体およびその用途